Saturday, 21 May, 2022
TopicCovaxin

Topic: Covaxin

Drug authority clears Covaxin, Corbevax for children aged 5 to 12

ThePrint Team -
DGCI also allowed emergency use of Zycov-D (Zydus Cadila vaccine) for children above 12 years.

As booster uptake lags in pvt sector, officials say health system can’t be in Covid mode forever

Abantika Ghosh -
Third Covid vaccine dose available only in pvt hospitals. Health officials say routine procedures need to be brought back on track, but govt hospitals could be brought in if needed.

WHO move to suspend Covaxin’s UN supply won’t affect trips to UK, US & over 90 nations, govt says

Abantika Ghosh -
Bharat Biotech is believed to have assured Government of India that it will ‘quickly’ reply to WHO about ‘deficiencies found in its manufacturing’ during an inspection last month.

Covaxin to be evaluated as Covid-19 vaccine candidate in US as FDA lifts clinical hold

PTI -
As many as 110 countries have agreed to mutual recognition of Covid-19 vaccination certificates with India that includes vaccination using Covaxin.

Covaxin supplies, trial group size — why there’s a delay in Covid vaccine for younger kids

Abantika Ghosh -
Monthly Covaxin output between 5.5-6.5 cr. Country needs at least 15 cr doses for full coverage 15-18 age group. Choice of 6 μg dose reduced manufacturing capacity, says Bharat Biotech.

ICMR received Rs 171.74 cr in royalty from sale of Covaxin till 31 Jan, govt tells Rajya Sabha

Abantika Ghosh -
ICMR and Bharat Biotech developed Covaxin together, and MoS Health Bharati Pawar says in written reply that the research body spent Rs 35 crore on its development.

Why you won’t get Covishield, Covaxin at a chemist yet, despite full market approval

Abantika Ghosh -
Covishield and Covaxin have been fully authorised only for use in adults, and can only be used in a ‘programmatic setting’, which means you’ll still have to register on CoWin.

DCGI grants regular market approval to Covishield, Covaxin for use in adult population

Payal Banerjee -
Approval was granted under New Drugs & Clinical Trials Rules, 2019 citing conditions that Bharat Biotech & SII will submit clinical trials' data & vaccines will be supplied for programmatic setting.

Covishield, Covaxin prices may drop to Rs 275/dose after getting regular market approval

Payal Banerjee -
Bharat Biotech's Covaxin is currently priced at Rs 1,200 per dose while SII's Covishield costs Rs 780 at private facilities. Both the vaccines are only authorised for emergency use.

Not allowing Covishield, Covaxin retail sale meaningless. Indians need vaccines and boosters

ThePrint Team -
ThePrint view on the most important issues, instantly.
123...23Page 1 of 23

On Camera

YourTurn

Opinion

Title scene of Taarak Mehta ka ooltah chashmah.

Dear Taarak Mehta, you were our peak comfort content for 14 years. Now it’s time to retire

Yashika Singla -
Just like the Truman Show, all Taarak Mehta plots somehow feel the same for the past few years. It's fine to accept that ideas can go stale.
The Gyanvapi Mosque and Kashi Vishwanath Temple, Varanasi | Photo: Praveen Jain | ThePrint

Gyanvapi row and Places of Worship Act were born together. Now each wants to end the other

Credit: ThePrint Team

The LIC way or the Air India way — that is the multi-crore disinvestment question

Economy

An attendant refills a two-wheeler with fuel at a petrol pump in New Delhi Saturday | ANI

Under fire for spiraling inflation, Modi govt announces excise duty cut on fuels, LPG subsidy

Shubham Batra -
It has also decided to enhance the fertiliser subsidy for farmers, and reduce import duty on some raw materials. ‘It is always people first for us!’ tweets prime minister.

Defence

File photo of a defence personnel armed with a SiG 716 rifle near the Line of Control | Photo: Snehesh Alex Philip | ThePrint

India to ink ‘repeat order’ deal for 73,000 SiG 716 rifles from the US

Snehesh Alex Philip -
In February 2019, 72,400 SiG 716 rifles of 7.62 x 51mm calibre were contracted from SIG Sauer Inc, USA, under government's 'Buy (Global) category', through fast track procedure.

National Interest

Mandir or Masjid? New surveys not needed, just acceptance of truth & move towards reconciliation

Shekhar Gupta -
That temples were destroyed and mosques built is undisputed history. The past can’t be changed, but we can’t deny the wrongs of the past either before we consider reconciliation.

Follow us

Copyright © 2022 Printline Media Pvt. Ltd. All rights reserved.

×